578 related articles for article (PubMed ID: 34788600)
21. Heteromultimeric sarbecovirus receptor binding domain immunogens primarily generate variant-specific neutralizing antibodies.
Zang T; Osei Kuffour E; Baharani VA; Canis M; Schmidt F; Da Silva J; Lercher A; Chaudhary P; Hoffmann HH; Gazumyan A; Miranda IC; MacDonald MR; Rice CM; Nussenzweig MC; Hatziioannou T; Bieniasz PD
Proc Natl Acad Sci U S A; 2023 Dec; 120(51):e2317367120. PubMed ID: 38096415
[TBL] [Abstract][Full Text] [Related]
22. Shark nanobodies with potent SARS-CoV-2 neutralizing activity and broad sarbecovirus reactivity.
Chen WH; Hajduczki A; Martinez EJ; Bai H; Matz H; Hill TM; Lewitus E; Chang WC; Dawit L; Peterson CE; Rees PA; Ajayi AB; Golub ES; Swafford I; Dussupt V; David S; Mayer SV; Soman S; Kuklis C; Corbitt C; King J; Choe M; Sankhala RS; Thomas PV; Zemil M; Wieczorek L; Hart T; Duso D; Kummer L; Yan L; Sterling SL; Laing ED; Broder CC; Williams JK; Davidson E; Doranz BJ; Krebs SJ; Polonis VR; Paquin-Proulx D; Rolland M; Reiley WW; Gromowski GD; Modjarrad K; Dooley H; Joyce MG
Nat Commun; 2023 Feb; 14(1):580. PubMed ID: 36737435
[TBL] [Abstract][Full Text] [Related]
23. Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.
Garrett ME; Galloway JG; Wolf C; Logue JK; Franko N; Chu HY; Matsen FA; Overbaugh JM
Elife; 2022 Jan; 11():. PubMed ID: 35072628
[TBL] [Abstract][Full Text] [Related]
24. High-Resolution Linear Epitope Mapping of the Receptor Binding Domain of SARS-CoV-2 Spike Protein in COVID-19 mRNA Vaccine Recipients.
Nitahara Y; Nakagama Y; Kaku N; Candray K; Michimuko Y; Tshibangu-Kabamba E; Kaneko A; Yamamoto H; Mizobata Y; Kakeya H; Yasugi M; Kido Y
Microbiol Spectr; 2021 Dec; 9(3):e0096521. PubMed ID: 34756082
[TBL] [Abstract][Full Text] [Related]
25. BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection.
Cao Y; Yisimayi A; Jian F; Song W; Xiao T; Wang L; Du S; Wang J; Li Q; Chen X; Yu Y; Wang P; Zhang Z; Liu P; An R; Hao X; Wang Y; Wang J; Feng R; Sun H; Zhao L; Zhang W; Zhao D; Zheng J; Yu L; Li C; Zhang N; Wang R; Niu X; Yang S; Song X; Chai Y; Hu Y; Shi Y; Zheng L; Li Z; Gu Q; Shao F; Huang W; Jin R; Shen Z; Wang Y; Wang X; Xiao J; Xie XS
Nature; 2022 Aug; 608(7923):593-602. PubMed ID: 35714668
[TBL] [Abstract][Full Text] [Related]
26. SARS-CoV-2 spike produced in insect cells elicits high neutralization titres in non-human primates.
Li T; Zheng Q; Yu H; Wu D; Xue W; Xiong H; Huang X; Nie M; Yue M; Rong R; Zhang S; Zhang Y; Wu Y; Wang S; Zha Z; Chen T; Deng T; Wang Y; Zhang T; Chen Y; Yuan Q; Zhao Q; Zhang J; Gu Y; Li S; Xia N
Emerg Microbes Infect; 2020 Dec; 9(1):2076-2090. PubMed ID: 32897177
[TBL] [Abstract][Full Text] [Related]
27. Identification of a broad sarbecovirus neutralizing antibody targeting a conserved epitope on the receptor-binding domain.
Wang Y; Zhang Z; Yang M; Xiong X; Yan Q; Cao L; Wei P; Zhang Y; Zhang L; Lv K; Chen J; Liu X; Zhao X; Xiao J; Zhang S; Zhu A; Gan M; Zhang J; Cai R; Zhuo J; Zhang Y; Rao H; Qu B; Zhang Y; Chen L; Dai J; Cheng L; Hu Q; Chen Y; Lv H; So RTY; Peiris M; Zhao J; Liu X; Mok CKP; Wang X; Zhao J
Cell Rep; 2024 Jan; 43(1):113653. PubMed ID: 38175758
[TBL] [Abstract][Full Text] [Related]
28. Cross-neutralization of human and palm civet severe acute respiratory syndrome coronaviruses by antibodies targeting the receptor-binding domain of spike protein.
He Y; Li J; Li W; Lustigman S; Farzan M; Jiang S
J Immunol; 2006 May; 176(10):6085-92. PubMed ID: 16670317
[TBL] [Abstract][Full Text] [Related]
29. Peptide Platform as a Powerful Tool in the Fight against COVID-19.
Murdocca M; Citro G; Romeo I; Lupia A; Miersch S; Amadio B; Bonomo A; Rossi A; Sidhu SS; Pandolfi PP; Alcaro S; Sangiuolo FC; Novelli G
Viruses; 2021 Aug; 13(8):. PubMed ID: 34452531
[TBL] [Abstract][Full Text] [Related]
30. A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV.
Zhao G; He L; Sun S; Qiu H; Tai W; Chen J; Li J; Chen Y; Guo Y; Wang Y; Shang J; Ji K; Fan R; Du E; Jiang S; Li F; Du L; Zhou Y
J Virol; 2018 Sep; 92(18):. PubMed ID: 29950421
[TBL] [Abstract][Full Text] [Related]
31. Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody.
Pinto D; Park YJ; Beltramello M; Walls AC; Tortorici MA; Bianchi S; Jaconi S; Culap K; Zatta F; De Marco A; Peter A; Guarino B; Spreafico R; Cameroni E; Case JB; Chen RE; Havenar-Daughton C; Snell G; Telenti A; Virgin HW; Lanzavecchia A; Diamond MS; Fink K; Veesler D; Corti D
Nature; 2020 Jul; 583(7815):290-295. PubMed ID: 32422645
[TBL] [Abstract][Full Text] [Related]
32. Elicitation of Broadly Neutralizing Antibodies against B.1.1.7, B.1.351, and B.1.617.1 SARS-CoV-2 Variants by Three Prototype Strain-Derived Recombinant Protein Vaccines.
Yang Y; Zang J; Xu S; Zhang X; Yuan S; Wang H; Lavillette D; Zhang C; Huang Z
Viruses; 2021 Jul; 13(8):. PubMed ID: 34452287
[TBL] [Abstract][Full Text] [Related]
33. RBD-Fc-based COVID-19 vaccine candidate induces highly potent SARS-CoV-2 neutralizing antibody response.
Liu Z; Xu W; Xia S; Gu C; Wang X; Wang Q; Zhou J; Wu Y; Cai X; Qu D; Ying T; Xie Y; Lu L; Yuan Z; Jiang S
Signal Transduct Target Ther; 2020 Nov; 5(1):282. PubMed ID: 33247109
[TBL] [Abstract][Full Text] [Related]
34. Cross-reactive neutralization of SARS-CoV-2 by serum antibodies from recovered SARS patients and immunized animals.
Zhu Y; Yu D; Han Y; Yan H; Chong H; Ren L; Wang J; Li T; He Y
Sci Adv; 2020 Nov; 6(45):. PubMed ID: 33036961
[TBL] [Abstract][Full Text] [Related]
35. Glycan engineering of the SARS-CoV-2 receptor-binding domain elicits cross-neutralizing antibodies for SARS-related viruses.
Shinnakasu R; Sakakibara S; Yamamoto H; Wang PH; Moriyama S; Sax N; Ono C; Yamanaka A; Adachi Y; Onodera T; Sato T; Shinkai M; Suzuki R; Matsuura Y; Hashii N; Takahashi Y; Inoue T; Yamashita K; Kurosaki T
J Exp Med; 2021 Dec; 218(12):. PubMed ID: 34623376
[TBL] [Abstract][Full Text] [Related]
36. Diverse array of neutralizing antibodies elicited upon Spike Ferritin Nanoparticle vaccination in rhesus macaques.
Sankhala RS; Lal KG; Jensen JL; Dussupt V; Mendez-Rivera L; Bai H; Wieczorek L; Mayer SV; Zemil M; Wagner DA; Townsley SM; Hajduczki A; Chang WC; Chen WH; Donofrio GC; Jian N; King HAD; Lorang CG; Martinez EJ; Rees PA; Peterson CE; Schmidt F; Hart TJ; Duso DK; Kummer LW; Casey SP; Williams JK; Kannan S; Slike BM; Smith L; Swafford I; Thomas PV; Tran U; Currier JR; Bolton DL; Davidson E; Doranz BJ; Hatziioannou T; Bieniasz PD; Paquin-Proulx D; Reiley WW; Rolland M; Sullivan NJ; Vasan S; Collins ND; Modjarrad K; Gromowski GD; Polonis VR; Michael NL; Krebs SJ; Joyce MG
Nat Commun; 2024 Jan; 15(1):200. PubMed ID: 38172512
[TBL] [Abstract][Full Text] [Related]
37. Human neutralizing antibodies elicited by SARS-CoV-2 infection.
Ju B; Zhang Q; Ge J; Wang R; Sun J; Ge X; Yu J; Shan S; Zhou B; Song S; Tang X; Yu J; Lan J; Yuan J; Wang H; Zhao J; Zhang S; Wang Y; Shi X; Liu L; Zhao J; Wang X; Zhang Z; Zhang L
Nature; 2020 Aug; 584(7819):115-119. PubMed ID: 32454513
[TBL] [Abstract][Full Text] [Related]
38. Yeast-expressed SARS-CoV recombinant receptor-binding domain (RBD219-N1) formulated with aluminum hydroxide induces protective immunity and reduces immune enhancement.
Chen WH; Tao X; Agrawal AS; Algaissi A; Peng BH; Pollet J; Strych U; Bottazzi ME; Hotez PJ; Lustigman S; Du L; Jiang S; Tseng CK
Vaccine; 2020 Nov; 38(47):7533-7541. PubMed ID: 33039209
[TBL] [Abstract][Full Text] [Related]
39. Mosaic RBD nanoparticles protect against challenge by diverse sarbecoviruses in animal models.
Cohen AA; van Doremalen N; Greaney AJ; Andersen H; Sharma A; Starr TN; Keeffe JR; Fan C; Schulz JE; Gnanapragasam PNP; Kakutani LM; West AP; Saturday G; Lee YE; Gao H; Jette CA; Lewis MG; Tan TK; Townsend AR; Bloom JD; Munster VJ; Bjorkman PJ
Science; 2022 Aug; 377(6606):eabq0839. PubMed ID: 35857620
[TBL] [Abstract][Full Text] [Related]
40. The neutralizing breadth of antibodies targeting diverse conserved epitopes between SARS-CoV and SARS-CoV-2.
Xiong H; Sun H; Wang S; Yuan L; Liu L; Zhu Y; Zhang J; Huang Y; Qi R; Jiang Y; Ma J; Zhou M; Ma Y; Fu R; Yan S; Yue M; Wu Y; Wei M; Wang Y; Li T; Wang Y; Zheng Z; Yu H; Cheng T; Li S; Yuan Q; Zhang J; Guan Y; Zheng Q; Zhang T; Xia N
Proc Natl Acad Sci U S A; 2022 Aug; 119(34):e2204256119. PubMed ID: 35972965
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
